Plné znění - 2/2008 Sb. m. s.

Ministerstvo xxxxxxxxxxxx xxxx xxxxxxx, xx xxx 16. xxxxxxxxx 2007 xxxx generálním xxxxxxxxx XXXXXX, xxxxxxxxxxx Xxxxxxxxxxx úmluvy xxxxx xxxxxxx xx xxxxxx¹⁾, xxxxxxxx schválení nového xxxxx Přílohy I - Xxxxxxx xxxxxxxxxx xxxxx x xxxxx xxxxxxx.

Xxxxxxx X xxxxxxxxx x xxxxxxxx x xxxxxxx x článkem 34 xxxx. 3 Xxxxxx xxx 1. xxxxx 2008 x xxxxx xxxx xxxxxxxxx x xxxxxxxx x pro Xxxxxx republiku. Xxxx xxxxxx Xxxxxxx I x platnost přestává xxxxxx Xxxxxxx X Xxxxxxxxxxx xxxxxx proti xxxxxxx xx sportu xx xxxxx xxx xxx 2007, vyhlášená xxx x. 59/2007 Xx. x. x.

Xxxxxxxx xxxxx Přílohy X a xxxx xxxxxxx xx xxxxxxx xxxxxx xx xxxxxxxxx xxxxxxxx.

X1. ANABOLICKÉ LÁTKY

Xxxxxxxxxx xxxxx xxxx xxxxxxxx.

1. ANDROGENNÍ XXXXXXXXXX XXXXXXXX (XXX):

x. Xxxxxxxx * XXX, xxxxxxxxxx:

1-androstendiol (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3,17-xxxx); xxxxxxxxx (19-xxxxxxxxxxxxxxxx); bolasteron; xxxxxxxx; xxxxxxx (xxxxxxxx-1,4-xxxx-3,17-xxxx); xxxxxxx (17α-xxxxxxx-17β-xxxxxxxxxxxxxx-4-xxx[2,3-x]xxxxxxxx); dehydrochlormethyltestosteron (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); desoxymethyltestosteron (17α-metyl-5α-androst-2-en-17β-ol); xxxxxxxxxxx; xxxxxxxxxxxxx (19-xxx-17α-xxxxx-4-xx-17-xx); xxxxxxxxxxxxxx; formebolon; xxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); xxxxxxxxx; 4-xxxxxxxxxxxxxxxxxx (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); xxxxxxxxxx; klostebol; xxxxxxxxxx; xxxxxxxxxx; metandienon (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx (2α, 17α-dimetyl-5α-androstan-3-on-17β-ol); xxxxxxxxxxxxxx (17β-hydroxy-17α-metylestra-4,9-dien-3-on); xxxxxx-1-xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxx-4-xx-3-xx); xxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9,11-xxxxx-3-xx); xxxxxxxxxxxxxxxxx; xxxxxxxxx; xxxxxxxxx; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); xxxxxxxxxx; xxxxxxxxxxxxxx; xxxxxxxxxxxx; xxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); xxxxxxxxx; stanozolol; xxxxxxxxx; 1-xxxxxxxxxxx (17β-hydroxy-5α-androst-1-en-3-on); xxxxxxxxxxxxxxxxxxx (18α-xxxx-xxxxxx-4,9,11-xxxxx-17β-xx-3-xx); trenbolon x další látky x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky.

b. Xxxxxxxxx ** XXX:

Xxxxxxxxxxxxx (xxxxxxx-5-xx-3β,17β-xxxx), xxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, DHEA), testosteron x xxxxxxxxxxx metabolity x isomery:

5α-androstan-3α,17α-diol androst-5-en-3β,17α-diol

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (xxxxxxx-4-xx-3β,17β-xxxx)

5α-xxxxxxxxx-3β,17α-xxxx 5-xxxxxxxxxxxxx (xxxxxxx-5-xx-3,17-xxxx)

5α-xxxxxxxxx-3β,17β-xxxx xxx-xxxxxxxxxxxxxxxxxx

xxxxxxx-4-xx-3α,17α-xxxx 3α-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-5-xx-3β,17α-xxxx 19-xxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17α-xxxx 19-xxxxxxxxxxxxxxxxx

androst-5-en-3α,17β-diol

X xxxxxxxxx, xxx může xxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx steroid přirozeně, xxxx xx xxx xx to, že Xxxxxx obsahuje xxxx Xxxxxxxxx xxxxx a xxxx xxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxx xx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx xxxx xxxxxxxxxxx a/nebo xxxx xx xxxxxxxx jiný xxxxxxxxx xxxxx xx Xxxxxx Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx xxxxxx, xxxxx se xxxxxxxx xxxxxxxxx u xxxx xxx, xx xxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx. Xxxxxx xx xxx xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx v xxxxxxx xxxxxxx, xxxxx Xxxxxxxxx prokáže, xx xx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx nebo xxxxxxxxxx x/xxxx xxxxxxxxx xxxxx xx Vzorku Sportovce xxxxxxxx xxxxxxxxxxxxx nebo xxxxxxxxxxxx xxxxxx.

Xxxx xx mít za xx, xx Xxxxxx Xxxxxxxxx xxxxxxxx Xxxxxxxxx xxxxx x xxxxxxxxx xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx ve xxxxx xxxxxxxxx x xxx xxxxxxxxx xxxxxxxxxxx, xxxxx xxx xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (např. XXXX) xxxxxxxx, xx xx Zakázaná látka xxxxxxxxxx xxxxxx. X xxxxxxx xxxxxxx xxxx xxxxx provádět další xxxxxxx.

Xxxx se xxxxxxx výsledku analýzy xxxxxxxx xxxxxxxxxxx xx xxxxxxx xxxxxx, xxxxx xx xxxxxxxx xxxxxxxxx x lidí x xxxxx spolehlivá analytická xxxxxx (xxxx. IRMS) xxxxxxxxxxx exogenní xxxxx Xxxxxxxx xxxxx, xxx xxxxxxxx xxxxxx xxxxxxx Xxxxxxxx xxxxx, xxxx xxxx. xxxxxxxxx x xxxxxxxxxxx xxxxxxxxxxxx steroidními xxxxxxx, xxxx xxxx xxxxxxxxx xxxxxxxxx xxxxx X/X xxxxx než xxxxx (4) xx xxxxx (1) a xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (např. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx, provede příslušná Xxxxxxxxxxxxx organizace xxxxx xxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxxxxxxx xxxxxxxxxx testů.

Xx-xx xxxxxxxxxx xxxxxx xxxxx xxxxxxx, xxx xxxxxxxx xxxx laboratoří xxxxxx xxxx neobvyklý x xx xxxx xxxxxxxxx. Pokud xxxxxxxxx xxxxxxx, xx použití xxxxxxxxxx analytické xxxxxx (xxxx. XXXX) xxxxxxxx xxxxx Zakázané látky, xxxx xxxxx xxxxxxxx xxxxx xxxxxxx, x xxxx se mít xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx. Pokud xxxxxx xxxxxxx spolehlivá analytická xxxxxx (např. IRMS) x xxxxxx x xxxxxxxxx xxxxxxxxx 3 xxxxxxxxx xxxxx, xxxx xxxxxxx xxxxxxxxxxxxxx xxxxxx Xxxxxxxxx tím, xx xxxx příslušnou Xxxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxx 3 xxxxxxxx xxxxxxx xxxxxxxx bez xxxxxxxxxxx xxxxxxxx. Výsledek, xxxxx xxxxxxxxxx tuto longitudinální xxxxxx, xxxx xxxxxx xxxx neobvyklý. Xxxxx xxxxxxxxxxxxxx profil Sportovce, xxxxxxxx následnými testy, xxxx xxxxxxxxxxxx xxxxxxxx, xxxx xx xxx xxxxxxxxx za Pozitivní xxxxxxxxxxx xxxxx.

X xxxxxxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxxx xxxx xxx x xxxx trvale xxxxxxx xxxxxxxx endogenního xxxxxx ve xxxxxx xxxxxx koncentracích (xx/xx). Xxxxx xxxxxxxxx xxxxxx xxxxx xxxxxxxxx a xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (např. XXXX) xxxxxxxxxxx exogenní původ Xxxxxxxx xxxxx, xxxx xxx xxxxxxxxx xxxxx xxxxxxx xxxxxxxxxx následného xxxxx (xxxxxxxxxx testů).

Xxxxx xxxxxxxxx nahlásila Xxxxxxxxx laboratorní xxxxx 19-xxxxxxxxxxxxxxx, xxxx xx xx xxxxxxxxx xx xxxxxxx x xxxxxxxxxxx xxxxx xxxxxxxxxx xxxxxx Xxxxxxxx xxxxx. X xxxxxxx xxxxxxx není xxxxx xxxxxxxx další xxxxxxx.

V případě, xx Sportovec nebude xxxxxxxxxxxxx xxx xxxxxxx xxxxxxxxx, bude se xxx xx xx, xx Xxxxxx Xxxxxxxxx xxxxxxxx Xxxxxxxxx xxxxx.

2. Ostatní xxxxxxxxxx xxxxx, xxxxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxx modulátory androgenových xxxxxxxxx (SARM), tibolon, xxxxxxx, xxxxxxxxxx, xxx xx x xxxxxxxx xxxxx xx xx.

X2. XXXXXXX A XXXXXXXX XXXXX

Xxxxxxxxxxx látky x xxxxxx xxxxxxxxxx xxxxxxx xxxx xxxxxxxx:

1. Xxxxxxxxxxxx (EPO);

2. Xxxxxxx hormon (xXX), xxxxxxxx xxxxxxx xxxxxxx xxxxxxx (xxxx. XXX-1), mechanické xxxxxxx xxxxxxx (MGF);

3. Xxxxxxxxxxxxx (xxxx. LH, xXX), xxxxxxxx xxx x xxxx;

4. Xxxxxxxx;

5. Xxxxxxxxxxxxxx

x xxxxx xxxxx x xxxxxxxx chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxx Xxxxxxxxx xxxxxx xxxxxxxx, xx xxxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxxx xx xxxxxxxxxxxx stavem, xxxx xx mít xx xx, xx Vzorek xxxxxxxx Zakázanou xxxxx (xxx xx uvedeno xxxx) x případech, xxx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx xx indikátorů x/xxxx příslušné poměry xx Xxxxxx Sportovce xxxxxxx překročí xxxxxxx xxxxxxxx zjištěné u xxxx xxx, xx xxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx.

Xxxxx laboratoř xxxxxxxxx, po xxxxx xxxxxxxxxx xxxxxxxxxx metody, xx Xxxxxxxx xxxxx xx exogenního xxxxxx, xxxx xx xxx xx xx, xx Xxxxxx obsahuje Xxxxxxxxx xxxxx x xxxx xxxxxxx Xxxxxxxxx laboratorní xxxxx.

S3. XXXX-2 XXXXXXXX

Všichni xxxx-2 xxxxxxxx xxxxxx xxxxxx X- x X-xxxxxxx xxxx xxxxxxxx.

Xxxxxxxx xxxx formoterol, xxxxxxxxxx, salmeterol x xxxxxxxxxx, xxx xxxxx xx xxx inhalaci xxxxx xxxxxxx zkrácené xxxxxxxxxxxx xxxxxxx.

X xxxx xxxx xxxxxxx xxxxxxxx xxxxx xxxxxxxxxxxx xxxxxxx, xxxx nález xxxxxxxxxxx (xxxxx xxxx xxxxxxxxxx) xxxxx xxx 1000 xxxxxxxxx x 1 xxxxxxxxx xxxx xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx xxxxx, pokud Xxxxxxxxx xxxxxxxxx, xx xxxxxxxxxx xxxxxxxx xxx xxxxxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxxxx x inhalaci.

S4. XXXXXXXXXXX X XXXXXXXXXX XXXXXXX

Xxxxxxxxxxx xxxxxxx xxxx xxxxxxxx:

1. Xxxxxxxxxx xxxxxxxx, xxxxxxxxxx:

2. Xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (XXXX), xxxxxxxx:

3. Xxxxxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxxx:

4. Xxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx, xxx ne x xxxxxxxx xxxxx xx ně.

X5. XXXXXXXXX X XXXXXXX XXXXXXXXX XXXXX

Xxxxxxxxx látky xxxx xxxxxxxx. Zahrnují:

Xxxxxxxxx*, xxxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx alfa-reduktázy (xxxx. xxxxxxxxxx, dutasterid), xxxxxxxxxxxxxxx (xxxx. albumin, xxxxxxx, xxxxxxxxxxxxxxxxx) x další xxxxx s xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxxxxxx xxxxxxxx:

Acetazolamid, xxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxx, kyselina xxxxxxxxxx, xxxxxxxxx, spironolakton, xxxxxxxx (xxxx. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, chlorothiazid), xxxxxxxxxx x další xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky (xxxxx xxxxxxxxxxxx, který xxxx xxxxxxxx).

* Terapeutická xxxxxxx není xxxxxx, xxxxx moč Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx x xxxxxxxx xxxx podprahovou xxxxxxxx xxxx Xxxxxxxx xxxxx (xxxxx).

X1. XXXXXXXXX PŘENOSU XXXXXXX

Zakázané je xxxxxxxxxxx:

M2. XXXXXXXX X XXXXXXXXX MANIPULACE

M3. XXXXXX DOPING

Xxxxxxxxxxxxxx xxxxxxx buněk, xxxx, xxxxxxxx elementů, nebo xxxxxxxxxx xxxxxxx genů, xxxxx xxxx xxxxxxxxx xxxxxx xxxxxxxxx xxxxx, xx zakázané.

X6. XXXXXXXXXXX

Xxxxxxx xxxxxxxxxxx (xxxxxx xxxx xxxxxx xxxxxxxxxx xxxxxxxxx (X- x X-) xxxxxxx) xxxx zakázaná, x výjimkou derivátů xxxxxxxxx v xxxxxxx xxxxxx místního užití x xxxxxxxxxxx xxxxxxxxxx xx Xxxxxxxxxxxxxx xxxxxxxx xxx xxx 2008.

Xxxxxxxxxxx zahrnují:

Xxxxxxxxx, xxxxxxxxx**, amfepramon, amfetaminil, xxxxxxxxxx, xxxxxxxxx, benzfetamin, xxxxxxxxxxxxxxx, bromantan, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, efedrin****, etamivan, xxxxxxxxx, ethylamfetamin, xxxxxxxxxxx, xxxxxxxxxxx, fendimetrazin, xxxxxxxxx, xxxxxxxxxxx, fenkamfamin, fenkamin, xxxxxxxxxxx, fenprometamin, xxxxxxxxxxx, xxxxxxxxx, 4-xxxxxxxxxxxxxx (xxxxxxxx), xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxx***, xxxxxxxxxxx, xxxxxx, xxxxxxxxxxx, krotetamid, levmetamfetamin, xxxxxxxxx, xxxxxxxxxxx, meklofenoxát, xxxxxxxxxxxx (D-), xxxxxxxxxxxx****, xxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, norfenfluramin, xxxxxxxxx, xxxxxxxxx, oxilofrin, parahydroxyamfetamin, xxxxxxx, pentetrazol, p-methylamfetamin, xxxxxxxxx, propylhexedrin, xxxxxxxxx, xxxxxxxxxx, strychnin, xxxxxxxxxxxxx x xxxxx xxxxx x podobnou xxxxxxxxx xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxxxxxxxxx neuvedené výslovně xxxx xxxxxxxx x xxxxx oddíle bude xxxxxxxxxx xx xxxxxxxxxxx xxxxx xxxxx, xxxxx Xxxxxxxxx xxxxxxx, že xxxx xxxxxxxxx dostupnost x běžných xxxxxxxxx xxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxx je x xxx xxxxx pravděpodobnost, xx xxxx xxxxxxx xxxxxxxx xxxx dopingová xxxxx.

X7. XXXXXXXXX

Následující xxxxxxxxx xxxx xxxxxxxx:

Buprenorfin, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), xxxxxxxx x jeho deriváty, xxxxxxxxxxx, xxxxxxx, xxxxxx, xxxxxxxx, oxymorfon, xxxxxxxxxx, xxxxxxx.

S8. XXXXXXXXXXX

Kanabinoidy (např. xxxxx, xxxxxxxxx) xxxx xxxxxxxx.

X9. XXXXXXXXXXXXXXXXXXXX

Xxxxxxx xxxxxxxxxxxxxxxxxxxx xxxxxxxx xxxxxx, rektálně, xxxxxxxxxx xxxx xxxxxxxxxxxxx xxxxxxxx xxxx zakázané. Xxxxxx užití xxxxxxxx xxxxxxxxxxxxx výjimku.

Xxxx xxxxxxx xxxxxxxx xxxxxxxx (xxxxxxxxxxxx, xx xxxxx xxxxxx, xx okolí xxxxxx, epidurální, xx xxxx) x xxxxxxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxxx s xxxxxxxx xxxx uvedených.

Xxxxxxx přípravky podávané xx xxxxxx kožní (xxxxxx xxxxxxxxxxx/xxxxxxxxxx), ušní, xxxxx, xxxx, potíže xxxxx xxxxxxx xxxxxx, xxxxxxxx xxx x xxxxx nejsou xxxxxxxx x xxxxxxxxxx žádnou xxxxx terapeutické xxxxxxx.

P1. XXXXXXX

Xxxxxxx (etanol) xx xxxxxxxx xxxxx Xxx xxxxxxx v xxxxxxxxxxxxx sportech. Detekce xx xxxx provádět xxxxxxxx xxxxxxxx a/nebo xxxxxxxx krve. Xxxxxxx xxxxxxx xxx xxxxxxxx xxxxxxxxxxx pravidla (hematologická xxxxxxx) je xxx xxxxxx federaci uvedena x xxxxxxxxx.

∙ Xxxxxxxxxxxx xxxxx (FIA) (0.10 x/x)

∙ Xxxxxx (XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxx a parašutismus (XXX) (0.20 x/x)

∙ Xxxxxxxxxxx (FITA, XXX) (0.10 g/l)

∙ Moderní xxxxxxx (XXXX) xxx xxx xxxxxxxxxx xx xxxxxxxx (0.10 x/x)

∙ Xxxxxxxxxxx xxxxx (XXX) (0.10 x/x)

∙ Xxxxx xxxxxxxxxx (XXX) (0.30 g/l)

∙ Xxxxxxx (IPC) (0.10 g/l)

X2. XXXX-XXXXXXXXX

Xxxxx xxxx xxxxx určeno, xxxx-xxxxxxxxx xxxx xxxxxxxx xxxxx Při soutěži x xxxxxxxxxxxxx xxxxxxxx.

∙ Xxxxxxxxxxxx xxxxx (XXX)

∙ Billiard (XXXX)

∙ Boby (XXXX)

∙ Bridž (XXX)

∙ Xxxxxxx (XXX)

∙ Xxxxxxxxxx (XXX)

∙ Xxxxxxxx (XXXX) - "match xxxx" - xxx xxxxxxxxxxx

∙ Xxxxxxx (XXX)

∙ Xxxxxxx xxxxxx a xxxxxxxxxxxx (XXX)

∙ Xxxxxxxxxxx (XXXX, IPC) (xxxxxxxx xxxx Xxxx soutěž)

∙ Xxxxxxxx (FIS) - xxxxx na xxxxxx a xxxxxxxxxxx xxxxxxxx-xxxxx x X-xxxxx, x xxxxxxxxx X-xxxxx x "xxx air"

∙ Moderní pětiboj (XXXX) - xxx xxxxxxxxxx xx xxxxxxxx

∙ Xxxxxxxxxxx sport (XXX)

∙ Xxxxxxxx x xxxxxxx xxxxxx (XXXX, XXX "xxxxx")

∙ Střelba (XXXX, XXX) (xxxxxxxx také Xxxx xxxxxx)

∙ Xxxxx motorismus (XXX)

∙ Xxxxx (XXXX)

Xxxx-xxxxxxxxx xxxxxxxx následující xxxxx:

Xxxxxxxxxx, alprenolol, xxxxxxxx, betaxolol, xxxxxxxxxx, xxxxxxx, celiprolol, xxxxxxx, xxxxxxxxx, karvedilol, labetalol, xxxxxxxxxxx, xxxxxxxxxxxx, metoprolol, xxxxxxx, oxprenolol, xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxxx, xxx xx x xxxxxxxx xxxxx xx xx

"Specifické xxxxx"* xxxx vyjmenovány xxxx:

∙ Xxxxxxx Beta-2 xxxxxxxx x xxxxxxxx, xxxxx xxxxxxxxxxx (volného xxxx glukuronidu) xxx xxxxxxxx větším xxx 1000 ng/ml moči x clenbuterolu (xxxxxxx xx xxxxxxx X 1.2 Ostatní xxxxxxxxxx xxxxx);

∙ Inhibitory xxxx-xxxxxxxxx, xxxxxxxxxx;

∙ Xxxxx, kropropamid, xxxxxxxxxx, xxxxxxx, etamivan, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxx, isomethepten, xxxxxxxxxxxxxxx, meklofenoxát, p-metylamfetamin, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, ortetamin, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxx a xxxxxxx xxxxxxx stimulancia xxxxxxxxx xxxxxxxx x xxxxxx X6, xxx xxxxx Xxxxxxxxx xxxxxxx, že xxxxxxx xxxxxxxx xxxxxxx x oddíle X6;

∙ Xxxxxxxxxxx;

∙ Xxxxxxx Xxxxxxxxxxxxxxxxxxxx;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"V Xxxxxxx xxxxx být xxxxxxxxxxx xxxxxxxxxx látky, xxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxxxxx xxxx všeobecně xxxxxxxx x xxxxxxx xxxxxxxxx přípravcích, xxxx x nichž xx xxxxx xxxxxxxxxxxxxxx, xx xxxxx xxxxxxx xxxxxxxx xxxx xxxxxxxxx xxxxxxx." Xxxxxxxx xxxxxxxxxxxxxxx pravidla xxxxxxxxxx xxxxxxxx xxxxx xxxx xxxxxxxx xxxxxxx xxxxxx xx předpokladu, xx "...Sportovec může xxxxx xxxxxxxx, xx Xxxxxxx xxxxxxxxxx xxxxx xxxxxx zamýšleno ke xxxxxxx xxxxxxxxxxx xxxxxx...".

Xxxxxx xxxxxxx x. 2/2008 Sb. m. x. xxxxx xxxxxxxxx xxxx 31.1.2008.

Xxxxxx předpis č. 2/2008 Sb. m. x. byl xxxxxx xxxxxxx xxxxxxxxx č. 8/2009 Sb. m. s. x účinností xx 7.2.2009.

Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x odkazech není xxxxxxxxxxxxx, xxxxx xx xxxx netýká xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx předpisu.